Cargando…

A Novel Four-Gene Prognostic Signature as a Risk Biomarker in Cervical Cancer

BACKGROUND: Cervical cancer (CC) is a major malignancy affecting women worldwide, with limited treatment options for patients with advanced disease. The aim of this study was to identify novel prognostic biomarkers for CC. METHODS: RNA-Seq data from four Gene Expression Omnibus datasets (GSE5787, GS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jun, Zheng, Hua, Han, Yatian, Wang, Geng, Li, Yanbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758149/ https://www.ncbi.nlm.nih.gov/pubmed/33381538 http://dx.doi.org/10.1155/2020/4535820

Ejemplares similares

A Novel Four-Gene Signature as a Potential Prognostic Biomarker for Hepatocellular Carcinoma
por: Wang, Guangfeng, et al.
Publicado: (2021)

Identifying Prognostic Significance of RCL1 and Four-Gene Signature as Novel Potential Biomarkers in HCC Patients
por: Liu, Jun, et al.
Publicado: (2021)

A Novel Four Genes of Prognostic Signature for Uveal Melanoma
por: Liu, Yan, et al.
Publicado: (2022)

A four-DNA methylation signature as a novel prognostic biomarker for survival of patients with gastric cancer
por: Li, Chunmei, et al.
Publicado: (2020)

Novel exosome-related risk signature as prognostic biomarkers in glioblastoma
por: Ding, Mingyan, et al.
Publicado: (2023)

Identification of a TLR-Induced Four-lncRNA Signature as a Novel Prognostic Biomarker in Esophageal Carcinoma
por: Liu, Jing, et al.
Publicado: (2020)

Identification of a novel six‐gene signature with potential prognostic and therapeutic value in cervical cancer
por: Qu, Xinyu, et al.
Publicado: (2021)

Mining of immunological and prognostic-related biomarker for cervical cancer based on immune cell signatures
por: Wang, Nana, et al.
Publicado: (2022)

A four-lncRNA risk signature for prognostic prediction of osteosarcoma
por: Liu, Huanlong, et al.
Publicado: (2023)

Pyroptosis-Related Gene Signature Is a Novel Prognostic Biomarker for Sarcoma Patients
por: Wei, Dalong, et al.
Publicado: (2021)

A novel seven-gene signature as Prognostic Biomarker in Hepatocellular Carcinoma
por: Xie, Hui, et al.
Publicado: (2020)

Identification of four differentially methylated genes as prognostic signatures for stage I lung adenocarcinoma
por: Luo, Wei-Ming, et al.
Publicado: (2018)

Comprehensive Molecular Analyses of a TNF Family-Based Gene Signature as a Potentially Novel Prognostic Biomarker for Cervical Cancer
por: Ma, Yan, et al.
Publicado: (2022)

Comprehensive analysis of a novel four-lncRNA signature as a prognostic biomarker for human gastric cancer
por: Miao, Yan, et al.
Publicado: (2017)

A novel prognostic 6-gene signature for osteoporosis
por: Zhao, Yu, et al.
Publicado: (2022)

A novel prognostic signature based on four glycolysis‐related genes predicts survival and clinical risk of hepatocellular carcinoma
por: Chen, Zhihong, et al.
Publicado: (2021)

Identification of Significant Gene Signatures and Prognostic Biomarkers for Patients With Cervical Cancer by Integrated Bioinformatic Methods
por: Li, Xiaofang, et al.
Publicado: (2018)

Identification of significant genes signatures and prognostic biomarkers in cervical squamous carcinoma via bioinformatic data
por: He, Yunan, et al.
Publicado: (2020)

Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma
por: Son, Ju A, et al.
Publicado: (2022)

Immune-infiltration based signature as a novel prognostic biomarker in gastrointestinal stromal tumour
por: Wei, Zhe-Wei, et al.
Publicado: (2020)

Screening and identifying a novel M-MDSCs-related gene signature for predicting prognostic risk and immunotherapeutic responses in patients with lung adenocarcinoma
por: Wang, Geng-Chong, et al.
Publicado: (2023)

Identification of a Novel Risk Model: A Five-Gene Prognostic Signature for Pancreatic Cancer
por: Wang, Xiaoguang, et al.
Publicado: (2022)

A Novel Four-Gene Prognostic Signature for Prediction of Survival in Patients with Soft Tissue Sarcoma
por: Wu, Changwu, et al.
Publicado: (2021)

A Novel Prognostic Four-Gene Signature of Breast Cancer Identified by Integrated Bioinformatics Analysis
por: Zhao, Xiaoyu, et al.
Publicado: (2022)

Establishing and Validating an Aging-Related Prognostic Four-Gene Signature in Colon Adenocarcinoma
por: Zheng, Lian, et al.
Publicado: (2021)

Four transcription profile–based models identify novel prognostic signatures in oesophageal cancer
por: Liu, Tongyan, et al.
Publicado: (2019)

A Ferroptosis-Related Gene Signature Identified as a Novel Prognostic Biomarker for Colon Cancer
por: Qi, Xin, et al.
Publicado: (2021)

Identification of Key Pathways and Establishment of a Seven-Gene Prognostic Signature in Cervical Cancer
por: An, Ran, et al.
Publicado: (2022)

Novel Pyroptosis-Related Gene Signatures Identified as the Prognostic Biomarkers for Bladder Carcinoma
por: You, Jia, et al.
Publicado: (2022)

Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma
por: Xu, Lixia, et al.
Publicado: (2023)

A four-hypoxia-genes-based prognostic signature for oral squamous cell carcinoma
por: Zhao, Chenguang, et al.
Publicado: (2021)

Immune-Related Four-lncRNA Signature for Patients with Cervical Cancer
por: Zheng, Jianfeng, et al.
Publicado: (2020)

A novel ten-gene prognostic signature for cervical cancer based on CD79B-related immunomodulators
por: Pu, Dan, et al.
Publicado: (2022)

Developing mRNA signatures as a novel prognostic biomarker predicting high risk multiple myeloma
por: Wang, Jing, et al.
Publicado: (2023)

Eight Aging-Related Genes Prognostic Signature for Cervical Cancer
por: Yin, Meilin, et al.
Publicado: (2023)

A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses
por: Cao, Mianfu, et al.
Publicado: (2019)

Four m6A RNA Methylation Gene Signatures and Their Prognostic Values in Lung Adenocarcinoma
por: Wang, Yuzhu, et al.
Publicado: (2022)

Development of a novel immune-related genes prognostic signature for osteosarcoma
por: Wu, Zuo-long, et al.
Publicado: (2020)

FBXO5 acts as a novel prognostic biomarker for patients with cervical cancer
por: Jiang, Shan, et al.
Publicado: (2023)

Tumor microenvironment characterization in cervical cancer identifies prognostic relevant gene signatures
por: Peng, Linyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_momopqij231htom16cnhfdsrh6